COPD trials, also abroad
559 open COPD trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency has 1 site in Moldova and runs in 12 countries. If a site near you is full, another one may still take people.
See Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency in all 12 countries